{
  "doc": {
    "accession": "0001193125-23-198542",
    "filingType": "8-K",
    "filedDate": "2023-07-31",
    "companyName": "BIOGEN INC.",
    "cik": "0000875045"
  },
  "event": {
    "kind": "Merger",
    "secItem": "Item 1.01",
    "headline": "Entry into a Material Definitive Agreement.",
    "summary": "Biogen Inc. entered into an Agreement and Plan of Merger with River Acquisition, Inc. and Reata Pharmaceuticals, Inc., pursuant to which Merger Sub will be merged with and into Reata, with Reata surviving the Merger as a wholly-owned subsidiary of Biogen.",
    "effectiveDate": "2023-07-28"
  },
  "deal": {
    "buyer": "Biogen Inc.",
    "target": "Reata Pharmaceuticals, Inc."
  },
  "provenance": {
    "documents": [
      {
        "role": "primary_filing",
        "filename": "d454539d8k.htm",
        "sourceUrl": "https://www.sec.gov/Archives/edgar/data/875045/000119312523198542/d454539d8k.htm",
        "sha256": "e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855"
      }
    ]
  },
  "evidence": [
    {
      "field": "doc.accession",
      "sourceFile": "chunk_0001.txt",
      "sourceUrl": "https://www.sec.gov/Archives/edgar/data/875045/000119312523198542/d454539d8k.htm",
      "selector": "chunk:chunk_0001",
      "snippet": "of The Securities Exchange Act of 1934\nDate of report (Date of earliest event reported): July 28, 2023"
    },
    {
      "field": "doc.filingType",
      "sourceFile": "chunk_0001.txt",
      "sourceUrl": "https://www.sec.gov/Archives/edgar/data/875045/000119312523198542/d454539d8k.htm",
      "selector": "chunk:chunk_0001",
      "snippet": "CURRENT REPORT\nPursuant to Section 13 OR 15 (d)\nof The Securities Exchange Act of 1934"
    },
    {
      "field": "doc.filedDate",
      "sourceFile": "chunk_0011.txt",
      "sourceUrl": "https://www.sec.gov/Archives/edgar/data/875045/000119312523198542/d454539d8k.htm",
      "selector": "chunk:chunk_0011",
      "snippet": "BIOGEN INC.\nDate: July 31, 2023"
    },
    {
      "field": "doc.companyName",
      "sourceFile": "chunk_0001.txt",
      "sourceUrl": "https://www.sec.gov/Archives/edgar/data/875045/000119312523198542/d454539d8k.htm",
      "selector": "chunk:chunk_0001",
      "snippet": "BIOGEN INC.\n(Exact Name of Registrant as Specified in Charter)"
    },
    {
      "field": "doc.cik",
      "sourceFile": "chunk_0001.txt",
      "sourceUrl": "https://www.sec.gov/Archives/edgar/data/875045/000119312523198542/d454539d8k.htm",
      "selector": "chunk:chunk_0001",
      "snippet": "of The Securities Exchange Act of 1934\nDate of report (Date of earliest event reported): July 28, 2023"
    },
    {
      "field": "event.kind",
      "sourceFile": "chunk_0001.txt",
      "sourceUrl": "https://www.sec.gov/Archives/edgar/data/875045/000119312523198542/d454539d8k.htm",
      "selector": "chunk:chunk_0001",
      "snippet": "Item 1.01.\tEntry into a Material Definitive Agreement."
    },
    {
      "field": "event.secItem",
      "sourceFile": "chunk_0001.txt",
      "sourceUrl": "https://www.sec.gov/Archives/edgar/data/875045/000119312523198542/d454539d8k.htm",
      "selector": "chunk:chunk_0001",
      "snippet": "Item 1.01.\tEntry into a Material Definitive Agreement."
    },
    {
      "field": "event.headline",
      "sourceFile": "chunk_0001.txt",
      "sourceUrl": "https://www.sec.gov/Archives/edgar/data/875045/000119312523198542/d454539d8k.htm",
      "selector": "chunk:chunk_0001",
      "snippet": "Item 1.01.\tEntry into a Material Definitive Agreement."
    },
    {
      "field": "event.summary",
      "sourceFile": "chunk_0001.txt",
      "sourceUrl": "https://www.sec.gov/Archives/edgar/data/875045/000119312523198542/d454539d8k.htm",
      "selector": "chunk:chunk_0001",
      "snippet": "On July 28, 2023, Biogen Inc. (“”), River Acquisition, Inc. (“”), a Delaware corporation and a wholly-owned subsidiary of Biogen and Reata Pharmaceuticals, Inc. (“”) entered into an Agreement and Plan of Merger"
    },
    {
      "field": "event.effectiveDate",
      "sourceFile": "chunk_0001.txt",
      "sourceUrl": "https://www.sec.gov/Archives/edgar/data/875045/000119312523198542/d454539d8k.htm",
      "selector": "chunk:chunk_0001",
      "snippet": "Date of report (Date of earliest event reported): July 28, 2023"
    },
    {
      "field": "deal.buyer",
      "sourceFile": "chunk_0001.txt",
      "sourceUrl": "https://www.sec.gov/Archives/edgar/data/875045/000119312523198542/d454539d8k.htm",
      "selector": "chunk:chunk_0001",
      "snippet": "On July 28, 2023, Biogen Inc. (“”), River Acquisition, Inc. (“”), a Delaware corporation and a wholly-owned subsidiary of Biogen and Reata Pharmaceuticals, Inc."
    },
    {
      "field": "deal.target",
      "sourceFile": "chunk_0001.txt",
      "sourceUrl": "https://www.sec.gov/Archives/edgar/data/875045/000119312523198542/d454539d8k.htm",
      "selector": "chunk:chunk_0001",
      "snippet": "On July 28, 2023, Biogen Inc. (“”), River Acquisition, Inc. (“”), a Delaware corporation and a wholly-owned subsidiary of Biogen and Reata Pharmaceuticals, Inc."
    }
  ]
}
